Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Urinary Tract Infection II: Pathophysiology01:25

Urinary Tract Infection II: Pathophysiology

28
The pathophysiology of urinary tract infections (UTIs) encompasses several progressive stages, beginning with bacterial colonization and culminating in potential systemic complications if untreated. UTIs are primarily initiated by bacteria, such as Escherichia coli, which often originate from the gastrointestinal tract and migrate to the urinary system through the periurethral area. This migration can occur via several routes, including improper hygiene practices, sexual activity, or...
28
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

12.2K
The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
12.2K
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

4.5K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
4.5K
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic01:26

Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic

4.3K
Healthcare-associated infections (HAIs) occur in a healthcare facility while a person receives care for another ailment. This category also includes work-related infections among healthcare staff.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
4.3K
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

130
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
130
Bacterial Translocation and Protein Secretion01:26

Bacterial Translocation and Protein Secretion

64
Bacterial protein secretion involves translocation systems to ensure proteins reach their designated locations, including the plasma membrane, periplasm, outer membrane, or the external environment. These translocation systems are vital for bacterial physiology, supporting processes like membrane assembly, enzymatic activity in the periplasm, and interactions with the external environment. The division of labor between Sec and Tat pathways ensures efficiency in handling proteins with diverse...
64

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Mucin-induced metabolic reprogramming in <i>Pseudomonas aeruginosa</i> clinical isolates.

mSystems·2026
Same author

Environmental former <i>Massilia</i> group bacteria secrete metabolites that promote <i>Leptospira</i> growth.

mSystems·2026
Same author

Hybrid genomes of three multidrug-resistant <i>Salmonella enterica</i> serovar Newport (REPJJP01) isolates from exotic captive felids in North Dakota, USA.

Microbiology resource announcements·2026
Same author

Chronic suppression of a multidrug-resistant Pseudomonas aeruginosa in prosthetic joint infection using personalized bacteriophage treatment.

Nature communications·2026
Same author

Hydrogen-Deuterium Back-Exchange for High-Resolution Mass-Spectrometry-Based Metabolite Characterization.

Analytical chemistry·2026
Same author

Genetic and pharmacological inactivation of peptidoglycan remodeling increases antibiotic susceptibility of vancomycin-resistant Enterococcus faecium.

Nature communications·2026
Same journal

Six ways to put the public at the heart of science and policy.

Nature·2026
Same journal

The complex truth about trust in science.

Nature·2026
Same journal

Have people stopped trusting science? The data tell a surprising story.

Nature·2026
Same journal

How FAIR data are helping to build trust in science.

Nature·2026
Same journal

Scientists should recognize their own political biases to build public trust.

Nature·2026
Same journal

Harmonizing standards and resources for the medical genome.

Nature·2026
関連記事をすべて見る

関連する実験動画

Updated: Aug 21, 2025

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
06:51

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291

Published on: December 10, 2016

12.7K

エントロコキはクロストリディオイドス・ディフィッシルの病原性を増強する

Alexander B Smith1, Matthew L Jenior2, Orlaith Keenan1

  • 1Division of Protective Immunity, Children's Hospital of Philadelphia, Philadelphia, PA, USA.

Nature
|November 17, 2022
PubMed
まとめ
この要約は機械生成です。

機会性腸内細菌は 腸内代謝環境を変化させ クロストリディオイドの毒性を高めます 栄養の交換と代謝の再プログラムを含むこの相互作用は,C. difficileの適性と病原性を増加させます.

さらに関連する動画

Culturing and Maintaining Clostridium difficile in an Anaerobic Environment
11:13

Culturing and Maintaining Clostridium difficile in an Anaerobic Environment

Published on: September 14, 2013

39.0K
A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment
12:58

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment

Published on: May 25, 2017

9.1K

関連する実験動画

Last Updated: Aug 21, 2025

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
06:51

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291

Published on: December 10, 2016

12.7K
Culturing and Maintaining Clostridium difficile in an Anaerobic Environment
11:13

Culturing and Maintaining Clostridium difficile in an Anaerobic Environment

Published on: September 14, 2013

39.0K
A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment
12:58

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment

Published on: May 25, 2017

9.1K

科学分野:

  • 微生物学
  • 腸内微生物群の研究
  • 感染症

背景:

  • 胃腸には 宿主の健康や病気に影響を与える 複雑な多微生物群が存在します
  • 感染症において微生物の相互作用は極めて重要であるが,共生性または病原性微生物群が病原体の毒性に影響するメカニズムは完全に理解されていない.
  • クロストリディオイドス・ディフィシル感染 (CDI) は,腸内微生物群の障害によってしばしば悪化する主要な医療問題です.

研究 の 目的:

  • 抗生物質耐性オポルトニスティック病原体のグループであるエンテロコックスの拡大が,クロストリディオイドス・ディフィッシルの健康と病原化にどのように影響するかを調査する.
  • 腸内環境におけるエンテロコックとC. difficileの相互作用の基礎となる代謝メカニズムを解明する.
  • CDIの重症度における病原菌群の役割に関するメカニズム的洞察を提供すること.

主な方法:

  • 微生物の相互作用を in vivo で研究するために,感染のマウスモデルを使用した.
  • 腸内細菌によって形成された代謝の変化を分析した.
  • 腸球菌由来栄養素と代謝シグナルへの反応として,C. difficileの代謝の再プログラミングを調査した.
  • C. difficile 感染した患者から採取したサンプル

主要な成果:

  • 腸内細菌の膨張は,腸内のClostridioides difficileの適性と病原性を高める.
  • 腸内細菌は,栄養素の制限と交配によって腸内代謝の形を変えて,C. difficileに有益な発酵性アミノ酸 (ルシン,オルニチン) を供給する.
  • 腸球菌によるアルギニンの減少は代謝のシグナルとして作用し,C. difficileの毒性を増加させます.
  • 微生物の相互作用は,マウスモデルとヒトのCDI患者で観察されました.

結論:

  • 腸内細菌は腸内代謝環境を調節することで,C. difficileの病原性を促進する.
  • 栄養素の供給と枯渇を含む特定の代謝は,エンテロコックスの存在でC. difficileの強化された毒性を媒介する.
  • これらの発見は,C. difficile感染の重症性を決定する病原性微生物群の重要な役割を強調しています.